Assure Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-07-2024
- Paid Up Capital ₹ 0.95 M
as on 25-07-2024
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 14.22%
(FY 2023)
- Profit 62.53%
(FY 2023)
- Ebitda 41.48%
(FY 2023)
- Net Worth 32.32%
(FY 2023)
- Total Assets 55.85%
(FY 2023)
About Assure Life Science
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.95 M, as per Ministry of Corporate Affairs (MCA) records.
Sagar Batra and Om Batra serve as directors at the Company.
- CIN/LLPIN
U24232DL2008PTC177863
- Company No.
177863
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Assure Life Science Private Limited offer?
Assure Life Science Private Limited offers a wide range of products and services, including Herbal Soaps, Glycerine Soap, Body Cream, Moisturizing Cream, Cosmetics, Hair & Beauty Products, Skin Care Cosmetics, Face Wash, Foam Face Wash, Anti Infective Drugs & Medicines, Anti Infective Agent.
Who are the key members and board of directors at Assure Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sagar Batra  | Director | 08-May-2008 | Current |
| Om Batra | Director | 08-May-2008 | Current |
Financial Performance and Corporate Structure Insights of Assure Life Science.
Assure Life Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.22% increase. The company also saw a substantial improvement in profitability, with a 62.53% increase in profit. The company's net worth Soared by an impressive increase of 32.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Assure Life Science?
In 2023, Assure Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bansal Distributors Private Limited
Active
25 years 7 months Sagar Batra and Om Batra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Assure Life Science?
Unlock and access historical data on people associated with Assure Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Assure Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Assure Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
